HIV prevention drug could reduce cases globally but USAID cuts prevent access, say experts
- One year ago, the World Health Organization recommended that governments around the world prioritize expanded access to lenacapavir, an injectable version of the HIV prevention medication PrEP that requires only two injections annually.
- PrEP, which also comes in the form of daily oral medications and bimonthly
Unverified
- One year ago, the World Health Organization recommended that governments around the world prioritize expanded access to lenacapavir, an injectable version of the HIV prevention medication PrEP that requires only two injections annually.
- PrEP, which also comes in the form of daily oral medications and bimonthly
Sources: Guardian